
HPLC Verified
Research Grade
COA Published
Retatrutide 30mg
Retatrutide
CAS: 2381609-35-2
Triple GLP-1/GIP/glucagon receptor agonist. 98.9% purity. 30mg bulk vial; Phase 2 −28.7% at 48 weeks; sufficient supply for full 12-week research cycle at 2.5mg weekly.
Price
$329.99
15 in stock
HPLC verified · third-party tested · research use only
Specifications
Retatrutide — Research Overview
Triple GLP-1/GIP/glucagon receptor agonist. 98.9% purity. 30mg bulk vial; Phase 2 −28.7% at 48 weeks; sufficient supply for full 12-week research cycle at 2.5mg weekly.
Related Products

Semaglutide 3mg
Semaglutide
GLP-1 receptor agonist. 99.1% purity. Starter 3mg vial suited to initial dose-titration research; STEP-1 trial recorded −14.9% mean body weight at 68 weeks.
$49.99
CAS 910463-68-2

Semaglutide 6mg
Semaglutide
GLP-1 receptor agonist. 99.1% purity. Mid-range 6mg vial supports two-vial titration schedules; STEP-1 Phase 3 mean weight reduction −14.9% over 68 weeks.
$79.99
CAS 910463-68-2
Retatrutide 30mg
$329.99

